{"id":"https://openalex.org/W3207594635","doi":"https://doi.org/10.1186/s13023-021-02035-5","title":"Development of symptom-focused outcome measures for advanced and indolent systemic mastocytosis: the AdvSM-SAF and ISM-SAF\u00a9","display_name":"Development of symptom-focused outcome measures for advanced and indolent systemic mastocytosis: the AdvSM-SAF and ISM-SAF\u00a9","publication_year":2021,"publication_date":"2021-10-09","ids":{"openalex":"https://openalex.org/W3207594635","doi":"https://doi.org/10.1186/s13023-021-02035-5","mag":"3207594635","pmid":"https://pubmed.ncbi.nlm.nih.gov/34627355","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8501694"},"language":"en","primary_location":{"id":"doi:10.1186/s13023-021-02035-5","doi":"https://doi.org/10.1186/s13023-021-02035-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13023-021-02035-5","pdf_url":"https://ojrd.biomedcentral.com/track/pdf/10.1186/s13023-021-02035-5","source":{"id":"https://openalex.org/S71291065","display_name":"Orphanet Journal of Rare Diseases","issn_l":"1750-1172","issn":["1750-1172"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet Journal of Rare Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ojrd.biomedcentral.com/track/pdf/10.1186/s13023-021-02035-5","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086422682","display_name":"Fiona C. Taylor","orcid":"https://orcid.org/0000-0001-6474-4314","observed_orcids":["https://orcid.org/0000-0001-6474-4314"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Fiona Taylor","raw_affiliation_strings":["Adelphi Values, 225 Franklin St 10th Floor, Boston, MA, 02110, USA. fiona.taylor@adelphivalues.com","Adelphi Values, Boston, USA"],"raw_orcid":"https://orcid.org/0000-0001-6474-4314","affiliations":[{"raw_affiliation_string":"Adelphi Values, 225 Franklin St 10th Floor, Boston, MA, 02110, USA. fiona.taylor@adelphivalues.com","institution_ids":[]},{"raw_affiliation_string":"Adelphi Values, Boston, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077544148","display_name":"Cem Akin","orcid":"https://orcid.org/0000-0001-6301-4520","observed_orcids":["https://orcid.org/0000-0001-6301-4520","https://orcid.org/0000-0002-2247-9409"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cem Akin","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI, USA","University of Michigan, Ann Arbor, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]},{"raw_affiliation_string":"University of Michigan, Ann Arbor, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078736405","display_name":"Roger E. Lamoureux","orcid":"https://orcid.org/0000-0001-9018-2511","observed_orcids":["https://orcid.org/0000-0001-9018-2511"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roger E. Lamoureux","raw_affiliation_strings":["Adelphi Values, 225 Franklin St 10th Floor, Boston, MA, 02110, USA","Adelphi Values, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Values, 225 Franklin St 10th Floor, Boston, MA, 02110, USA","institution_ids":[]},{"raw_affiliation_string":"Adelphi Values, Boston, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112694052","display_name":"Brad Padilla","orcid":"https://orcid.org/0009-0006-1761-0034","observed_orcids":["https://orcid.org/0009-0006-1761-0034"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brad Padilla","raw_affiliation_strings":["Adelphi Values, 225 Franklin St 10th Floor, Boston, MA, 02110, USA","Adelphi Values, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Values, 225 Franklin St 10th Floor, Boston, MA, 02110, USA","institution_ids":[]},{"raw_affiliation_string":"Adelphi Values, Boston, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037549428","display_name":"Tanya Green","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100156","display_name":"Blueprint Medicines (United States)","ror":"https://ror.org/0142eak56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100156"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tanya Green","raw_affiliation_strings":["Blueprint Medicines, Cambridge, MA, USA","Blueprint Medicines, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blueprint Medicines, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210100156"]},{"raw_affiliation_string":"Blueprint Medicines, Cambridge, USA","institution_ids":["https://openalex.org/I4210100156"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109292881","display_name":"Anthony L. Boral","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100156","display_name":"Blueprint Medicines (United States)","ror":"https://ror.org/0142eak56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100156"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony L. Boral","raw_affiliation_strings":["Blueprint Medicines, Cambridge, MA, USA","Blueprint Medicines, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blueprint Medicines, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210100156"]},{"raw_affiliation_string":"Blueprint Medicines, Cambridge, USA","institution_ids":["https://openalex.org/I4210100156"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048099566","display_name":"Iyar Mazar","orcid":"https://orcid.org/0000-0001-9371-5918","observed_orcids":["https://orcid.org/0000-0001-9371-5918"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Iyar Mazar","raw_affiliation_strings":["Adelphi Values, 225 Franklin St 10th Floor, Boston, MA, 02110, USA","Sanofi, Cambridge, MA, USA","Adelphi Values, Boston, USA","Sanofi, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Values, 225 Franklin St 10th Floor, Boston, MA, 02110, USA","institution_ids":[]},{"raw_affiliation_string":"Sanofi, Cambridge, MA, USA","institution_ids":[]},{"raw_affiliation_string":"Adelphi Values, Boston, USA","institution_ids":[]},{"raw_affiliation_string":"Sanofi, Cambridge, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022871185","display_name":"Brenton G. Mar","orcid":"https://orcid.org/0000-0002-3857-9324","observed_orcids":["https://orcid.org/0000-0002-3857-9324"]},"institutions":[{"id":"https://openalex.org/I4210100156","display_name":"Blueprint Medicines (United States)","ror":"https://ror.org/0142eak56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100156"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brenton Mar","raw_affiliation_strings":["Blueprint Medicines, Cambridge, MA, USA","Blueprint Medicines, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blueprint Medicines, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210100156"]},{"raw_affiliation_string":"Blueprint Medicines, Cambridge, USA","institution_ids":["https://openalex.org/I4210100156"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035900499","display_name":"Alan L. Shields","orcid":"https://orcid.org/0000-0003-3362-3135","observed_orcids":["https://orcid.org/0000-0003-3362-3135"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan L. Shields","raw_affiliation_strings":["Adelphi Values, 225 Franklin St 10th Floor, Boston, MA, 02110, USA","Adelphi Values, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Values, 225 Franklin St 10th Floor, Boston, MA, 02110, USA","institution_ids":[]},{"raw_affiliation_string":"Adelphi Values, Boston, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052378579","display_name":"Frank Siebenhaar","orcid":"https://orcid.org/0000-0003-4532-1644","observed_orcids":["https://orcid.org/0000-0003-4532-1644"]},"institutions":[{"id":"https://openalex.org/I39343248","display_name":"Humboldt-Universit\u00e4t zu Berlin","ror":"https://ror.org/01hcx6992","country_code":"DE","type":"education","lineage":["https://openalex.org/I39343248"]},{"id":"https://openalex.org/I4210139777","display_name":"Berlin Institute of Health at Charit\u00e9 - Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/0493xsw21","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210139777","https://openalex.org/I7877124"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Frank Siebenhaar","raw_affiliation_strings":["Dermatological Allergology, Department of Dermatology and Allergy, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatological Allergology, Department of Dermatology and Allergy, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany","institution_ids":["https://openalex.org/I39343248","https://openalex.org/I4210139777","https://openalex.org/I7877124"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5086422682"],"corresponding_institution_ids":[],"apc_list":{"value":2680,"currency":"USD","value_usd":2680},"apc_paid":{"value":2680,"currency":"USD","value_usd":2680},"fwci":1.0064,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.72619279,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":98},"biblio":{"volume":"16","issue":"1","first_page":"414","last_page":"414"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.8939999938011169,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.8939999938011169,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13117","display_name":"Health Education and Validation","score":0.02410000003874302,"subfield":{"id":"https://openalex.org/subfields/2922","display_name":"Research and Theory"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.022600000724196434,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-systemic-mastocytosis","display_name":"advanced systemic mastocytosis","score":0.9449999928474426},{"id":"https://openalex.org/keywords/indolent-systemic-mastocytosis","display_name":"indolent systemic mastocytosis","score":1.0},{"id":"https://openalex.org/keywords/patient-reported-outcome-measures","display_name":"patient-reported outcome measures","score":0.8370000123977661},{"id":"https://openalex.org/keywords/symptom-assessment","display_name":"symptom assessment","score":0.875},{"id":"https://openalex.org/keywords/content-validity","display_name":"content validity","score":0.7860000133514404},{"id":"https://openalex.org/keywords/cognitive-debriefing","display_name":"cognitive debriefing","score":0.8050000071525574},{"id":"https://openalex.org/keywords/patient-reported-symptoms","display_name":"patient-reported symptoms","score":0.3930000066757202},{"id":"https://openalex.org/keywords/questionnaire-development","display_name":"questionnaire development","score":0.628000020980835}],"concepts":[{"id":"https://openalex.org/C2780581156","wikidata":"https://www.wikidata.org/wiki/Q112670","display_name":"Systemic mastocytosis","level":3,"score":0.7840837240219116},{"id":"https://openalex.org/C202695956","wikidata":"https://www.wikidata.org/wiki/Q2669680","display_name":"Debriefing","level":2,"score":0.6876254677772522},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5058231353759766},{"id":"https://openalex.org/C155911762","wikidata":"https://www.wikidata.org/wiki/Q422321","display_name":"Blueprint","level":2,"score":0.4332130253314972},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.37066400051116943},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33860576152801514},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20968183875083923},{"id":"https://openalex.org/C509550671","wikidata":"https://www.wikidata.org/wiki/Q126945","display_name":"Medical education","level":1,"score":0.10697418451309204},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.09102451801300049},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000071066","descriptor_name":"Patient Reported Outcome Measures","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D034721","descriptor_name":"Mastocytosis, Systemic","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1186/s13023-021-02035-5","doi":"https://doi.org/10.1186/s13023-021-02035-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13023-021-02035-5","pdf_url":"https://ojrd.biomedcentral.com/track/pdf/10.1186/s13023-021-02035-5","source":{"id":"https://openalex.org/S71291065","display_name":"Orphanet Journal of Rare Diseases","issn_l":"1750-1172","issn":["1750-1172"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet Journal of Rare Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8501694","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8501694","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet J Rare Dis","raw_type":"Text"},{"id":"pmid:34627355","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34627355","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet journal of rare diseases","raw_type":"Journal Article"},{"id":"pmh:oai:deepblue.lib.umich.edu:2027.42/173790","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/2027.42/173790","pdf_url":null,"source":{"id":"https://openalex.org/S4306400393","display_name":"Deep Blue (University of Michigan)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I27837315","host_organization_name":"University of Michigan","host_organization_lineage":["https://openalex.org/I27837315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:e7491e39c049481e9d007aca4e635049","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/e7491e39c049481e9d007aca4e635049","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-12 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s13023-021-02035-5","doi":"https://doi.org/10.1186/s13023-021-02035-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13023-021-02035-5","pdf_url":"https://ojrd.biomedcentral.com/track/pdf/10.1186/s13023-021-02035-5","source":{"id":"https://openalex.org/S71291065","display_name":"Orphanet Journal of Rare Diseases","issn_l":"1750-1172","issn":["1750-1172"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet Journal of Rare Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3207594635.pdf","grobid_xml":"https://content.openalex.org/works/W3207594635.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W151300514","https://openalex.org/W570387683","https://openalex.org/W809016622","https://openalex.org/W2128536774","https://openalex.org/W2142507445","https://openalex.org/W2166444516","https://openalex.org/W2181218493","https://openalex.org/W2293641373","https://openalex.org/W2541448135","https://openalex.org/W2565342730","https://openalex.org/W2792037535","https://openalex.org/W2793174446","https://openalex.org/W2904893969"],"related_works":["https://openalex.org/W2541448135","https://openalex.org/W6901911680","https://openalex.org/W4210695617","https://openalex.org/W3159947714","https://openalex.org/W4391534553","https://openalex.org/W2994819040","https://openalex.org/W6958920266","https://openalex.org/W2994737028","https://openalex.org/W4360941991","https://openalex.org/W2340433199"],"abstract_inverted_index":{"BACKGROUND:":[0],"Advanced":[1,186],"systemic":[2,6,11,107],"mastocytosis":[3,7,12],"(AdvSM),":[4],"indolent":[5],"(ISM),":[8],"and":[9,38,43,76,84,97,104,128,132,139,149,159,167,178,193,214,220,224,236,245],"smoldering":[10],"(SSM)":[13],"are":[14,41,238],"rare":[15],"diseases":[16],"characterized":[17],"by":[18,157,161,176,180,228],"neoplastic":[19],"mast":[20],"cell":[21],"infiltration":[22],"of":[23,100,106,112,231],"more":[24],"than":[25],"one":[26],"organ.":[27],"A":[28,110],"content-valid":[29,239],"patient-reported":[30,183],"outcome":[31],"(PRO)":[32],"questionnaire":[33,68,129],"that":[34,40,90],"assesses":[35],"relevant":[36],"signs":[37,103],"symptoms":[39,105,242],"important":[42],"understandable":[44],"to":[45],"individuals":[46],"with":[47,74,117,212],"a":[48],"condition":[49],"is":[50],"critical":[51],"for":[52,79],"assessing":[53],"new":[54],"treatment":[55],"benefit":[56],"as":[57,59,226],"well":[58],"supporting":[60],"product":[61],"labeling":[62],"claims.":[63],"Notably,":[64],"no":[65],"such":[66],"PRO":[67],"has":[69],"been":[70],"developed":[71,204],"in":[72,81,154,172],"accordance":[73],"regulatory":[75,140],"scientific":[77],"guidelines":[78],"use":[80],"AdvSM,":[82,146],"ISM,":[83],"SSM":[85],"patient":[86,122,133],"populations.":[87],"To":[88],"fill":[89],"gap,":[91],"this":[92],"study":[93],"documents":[94],"the":[95,173,185,218,229],"development":[96],"content":[98],"validity":[99],"instruments":[101],"evaluating":[102],"mastocytosis.":[108],"METHODS:":[109],"review":[111],"peer-reviewed":[113],"literature,":[114,155,174],"advice":[115],"meetings":[116],"clinical":[118],"therapeutic":[119],"area":[120],"experts,":[121],"concept":[123,126],"elicitation":[124],"interviews,":[125],"selection":[127],"construction":[130],"meetings,":[131],"cognitive":[134],"debriefing":[135,210],"interviews":[136,211],"were":[137,152,170,203,222],"conducted,":[138],"feedback":[141],"was":[142],"incorporated.":[143],"RESULTS:":[144],"For":[145,163],"26":[147],"sign-":[148,166],"symptom-level":[150,168],"concepts":[151,169],"identified":[153,171],"39":[156,175],"clinicians,":[158,177],"33":[160],"patients.":[162,181,232],"ISM/SSM,":[164],"38":[165],"57":[179],"Two":[182],"instruments,":[184],"Systemic":[187,195],"Mastocytosis":[188,196],"Symptom":[189,197],"Assessment":[190,198],"Form":[191,199],"(AdvSM-SAF)":[192],"Indolent":[194],"(ISM-SAF)(\u00a9Blueprint":[200],"Medicines":[201],"Corporation),":[202],"based":[205],"on":[206],"consolidated":[207],"findings.":[208],"Cognitive":[209],"AdvSM":[213,244],"ISM":[215,246],"patients":[216],"showed":[217],"AdvSM-SAF":[219,235],"ISM-SAF":[221,237],"understood":[223],"interpreted":[225],"intended":[227],"majority":[230],"CONCLUSION:":[233],"The":[234],"tools":[240],"measuring":[241],"from":[243],"patients'":[247],"perspective.":[248]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-10-25T00:00:00"}